By: Press Release | January 30, 2015
Andrew Fish, executive director of AdvaMedDx, issued a statement today in response to President Barack Obama’s newly announced Precision Medicine Initiative.
By: Statement | January 29, 2015
“AdvaMed would like to commend Sens. Alexander and Burr for their leadership on this important issue. We share their goal of improving the efficiency and predictability of processes at both NIH and FDA to ensure patients have timely access to the latest medical advancements."
By: Statement | January 28, 2015
“AdvaMed welcomes reforms that India is pursuing to make it easier to do business in India, including a recent change in Foreign Direct Investment policy that clears the way for greater foreign participation and investment in India’s medical device market, and we are encouraged by continuing efforts to create an appropriate regulatory framework for devices distinct from pharmaceuticals. "